MustGrow Biologics Corp. logo

MustGrow Biologics Corp. (CA62822A1030)

Market Open
17 Jul, 20:00
XSTU XSTU
0. 21
+0
+0.9615%
- Market Cap
- P/E Ratio
- Div Yield
20,000 Volume
0 Eps
0.21
Previous Close
Add Transaction
Day Range
0.2 0.25
Year Range
0.2 0.58
Want to track CA62822A1030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CA62822A1030 trading today higher at €0.21, an increase of 0.9615% from yesterday's close, completing a monthly increase of 1.9417% or €0. Over the past 12 months, CA62822A1030 stock lost -47.1033%.
CA62822A1030 pays dividends to its shareholders, with the most recent payment made on Dec 24, 2024. The next estimated payment will be in 24 Dec 2024 on Dec 24, 2024 for a total of €0.104.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on BATS (USD).

CA62822A1030 Chart

Some of the Top Growth Stocks Reside in this ETF

Some of the Top Growth Stocks Reside in this ETF

In the late stages of July and into the early part of this month, previously high-flying growth stocks were repudiated in a big way. The good news is that the sell-off could prove to be a buying opportunity in select growth equities and related ETFs.

Etftrends | 1 year ago
Moat Stocks Gain as Mega-Caps Falter

Moat Stocks Gain as Mega-Caps Falter

July saw a notable shift in U.S. equities. The Magnificent 7 tech sell-off drove a divergence between mega-cap growth stocks and the more value-oriented and smaller large-cap segment of the market.

Etftrends | 1 year ago
Moat Stocks Steady Amid Tech's Market Surge

Moat Stocks Steady Amid Tech's Market Surge

By Coulter Regal, CFA, Product Manager As U.S. equities climbed, Morningstar's Moat Index kept its value bias, offering a diversifier from concentration risk and the SMID Moat Index shifted from tech to materials and utilities as it seeks valuation opportunities. U.S.

Etftrends | 2 years ago

MustGrow Biologics Corp. (CA62822A1030) FAQ

What is the stock price today?

The current price is €0.21.

On which exchange is it traded?

MustGrow Biologics Corp. is listed on XSTU.

What is its stock symbol?

The ticker symbol is CA62822A1030.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has MustGrow Biologics Corp. ever had a stock split?

No, there has never been a stock split.

MustGrow Biologics Corp. Profile

Insurance Industry
Financials Sector
Thomas J. Nimbley CEO
XSTU Exchange
- ISIN
US Country
- Employees
23 Dec 2024 Last Dividend
- Last Split
- IPO Date

Overview

SHL Telemedicine Ltd. is a pioneering company in the field of personal telemedicine solutions, operating on a global scale with a focus on markets in Israel, Europe, and beyond. Established in 1987 and headquartered in Tel Aviv, Israel, SHL Telemedicine leverages telephonic and internet communication technologies to offer innovative healthcare services. The company caters to a diverse client base including patients, health insurance companies, hospitals, clinics, physicians, and other healthcare providers. A hallmark of their operation is the use of personal telemedicine devices that support remote monitoring and diagnostics, fostering a proactive approach to healthcare. Additionally, SHL Telemedicine has established strategic collaboration agreements with prestigious institutions like Mayo Clinic and the Hebrew University of Jerusalem and the Hadassah Medical Center, enhancing its research and development capabilities and reinforcing its commitment to healthcare innovation.

Products and Services

  • smartheart: A personal mobile 12-lead ECG device designed for the early detection of heart attacks. This innovative device enables users to monitor their heart health in real-time and share ECG readings directly with healthcare professionals.
  • CardioSen'C: This device represents a leap in personal health technology, being a cellular-digital 12-lead ECG transmitter. It facilitates the quick and early detection of cardiac events, allowing for faster response times and improved patient outcomes.
  • Cardio'B: A portable device capable of transmitting 12-lead ECG readings, Cardio'B supports patients in maintaining regular monitoring of their cardiac health, ensuring ongoing communication with their healthcare providers.
  • Cardio Beeper 12/12: A hand-held ECG transmitter device intended for personal use, providing full ECG readings transmission to the monitoring center. It epitomizes convenience and efficacy in heart monitoring technology.
  • Central communication module: Serving as a telecommunication device, it transmits medical data from various monitoring devices to SHL Telemedicine's centers, facilitating comprehensive remote healthcare management.
  • TeleWeight: A trans-telephonic weight monitoring device designed for personal use, enabling users to track their weight remotely and share this data with healthcare providers for ongoing monitoring and support.
  • TelePress: This remote blood pressure monitoring device allows patients to manage and share their blood pressure readings from the comfort of their home, supporting continuous hypertension management.
  • TeleBreather: An electronic handheld device for testing lung function remotely. TeleBreather simplifies the process of monitoring respiratory health, crucial for patients with chronic respiratory conditions.
  • TelePulse Oximeter: A diagnostic tool for personal use that measures the saturation level of oxygen in the blood and pulse rate. This device is essential for patients requiring constant monitoring of their oxygen levels, especially in the context of respiratory illnesses.

Contact Information

Address: 655 Broad Street
Phone: 1 800 225 1852